Senomyx Inc (SNMX) 2.49 $SNMX Senomyx (SNMX) in Focus:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Senomyx Inc (SNMX) 2.49 $SNMX

Senomyx (SNMX) in Focus: Stock Adds 7.3% in Session
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 7:45AM CDT
Senomyx Inc. (SNMX) was a big mover last session, as the company saw its shares rise over 7% on the day.
BGS: 48.46 (+0.73), SNMX: 2.49 (+0.05)

Will Senomyx (SNMX) Continue to Surge Higher?
Zacks Equity Research - Zacks Investment Research - Fri May 27, 8:16AM CDT
As of late, it has definitely been a great time to be an investor in Senomyx Inc. (SNMX).
SNMX: 2.49 (+0.05)

Senomyx reports 1Q loss
Automated Insights - Thu Apr 28, 4:19PM CDT
SAN DIEGO (AP) _ Senomyx Inc. (SNMX) on Thursday reported a loss of $2.4 million in its first quarter.
SNMX: 2.49 (+0.05)

SENOMYX ANNOUNCES FIRST QUARTER 2016 FINANCIAL RESULTS
PR Newswire - Thu Apr 28, 3:01PM CDT
Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients for the food, beverage, and ingredient supply industries, today reported financial results for the first quarter ended March 31, 2016. Total revenues for the first quarter 2016 were $6.3 million including $2.1 million in commercial revenues.
SNMX: 2.49 (+0.05)

Senomyx, Inc. First Quarter 2016 Earnings Conference Call Scheduled for April 28, 2016
GlobeNewswire - Mon Apr 18, 3:15PM CDT
Senomyx, Inc. (NASDAQ:SNMX) will release its financial results for the first quarter ended March 31, 2016 on Thursday, April 28, 2016, after the close of the U.S. financial markets. The Company will also host a conference call with a live Internet broadcast that will provide a corporate update and a review of its first quarter results on the same day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).
SNMX: 2.49 (+0.05)

SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE 15TH ANNUAL NEEDHAM HEALTHCARE CONFERENCE
PR Newswire - Thu Mar 31, 4:00PM CDT
Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients for the food, beverage, and flavor industries, announced today that John Poyhonen, the Company's President and Chief Executive Officer, and Tony Rogers, Senior Vice President and Chief Financial Officer, will present an overview of Senomyx's technology and business model on Wednesday, April 13, at 11:20 a.m. Eastern Time (8:20 a.m. Pacific Time) during the 15th Annual Needham Healthcare Conference. The conference is taking place at the Westin Grand Central Hotel in New York, NY. During the presentation, Mr. Poyhonen and Mr. Rogers will discuss corporate developments including the Company's novel flavor ingredients and its business strategy.
SNMX: 2.49 (+0.05)

SENOMYX ANNOUNCES FOURTH QUARTER AND FULL YEAR 2015 FINANCIAL RESULTS
PR Newswire - Thu Mar 03, 3:01PM CST
Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients for the food, beverage, and ingredient supply industries, today reported financial results for the fourth quarter and year ended December 31, 2015. Revenues for 2015 were $24.9 million and the Company ended 2015 with $23.0 million in cash and highly liquid investments.
SNMX: 2.49 (+0.05)

BUYINS.NET: ECH, GRU, SNMX, EUO, FNGN Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Wed Jan 27, 6:37AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of iShares MSCI Chile Investable Market Index Fund (NYSE:ECH), ELEMENTS - MLCX GRAINS (NYSE:GRU), Senomyx Inc (NASDAQ:SNMX), Eurocontrol Technics Group Inc (NYSE:EUO), Financial Engines Inc (NASDAQ:FNGN) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
FNGN: 25.64 (+0.68), ECH: 37.17 (+0.65), EUO: 24.55 (+0.10), SNMX: 2.49 (+0.05), GRU: 4.23 (+0.09)

SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE 18TH ANNUAL NEEDHAM GROWTH CONFERENCE
PR Newswire - Fri Jan 08, 3:15PM CST
Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients for the food, beverage, and flavor industries, announced today that John Poyhonen, the Company's President and Chief Executive Officer, and Tony Rogers, Senior Vice President and Chief Financial Officer, will present an overview of Senomyx's technology and programs on Wednesday, January 13, at 1:30 p.m. Eastern Time (10:30 a.m. Pacific Time) during the 18th Annual Needham Growth Conference. The conference is taking place at the New York Palace Hotel in New York, NY. During the presentation, Mr. Poyhonen and Mr. Rogers will discuss corporate developments including the Company's pipeline of novel flavor ingredients and its business strategy.
SNMX: 2.49 (+0.05)

Stock to Watch: Senomyx Up 6.3% (SNMX)
Comtex SmarTrend(R) - Wed Dec 23, 12:48PM CST
Senomyx (NASDAQ:SNMX) is one of today's best performing low-priced stocks, up 6.3% to $4.06 on 1.0x average daily volume. Senomyx has traded 266,000 shares thus far today, vs. average volume of 255,000 shares per day. The stock has outperformed the Dow (6.3% to the Dow's 0.6%) and outperformed the S&P 500 (6.3% to the S&P's 0.8%) during today's trading.
SNMX: 2.49 (+0.05)

Identifying Opportunity, Placing Risk - Analyst Notes on Five Star Quality Care, Senomyx, Ring Energy and Sophiris Bio
ACCESSWIRE - Fri Dec 18, 6:30AM CST
NEW YORK, NY / ACCESSWIRE / December 18, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Five Star Quality Care Inc. (NYSE: FVE), Senomyx Inc. (NASDAQ: SNMX), Ring Energy Inc. (NYSE: REI) and Sophiris Bio Inc. (NASDAQ: SPHS). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
FVE: 2.36 (+0.04), SPHS: 2.44 (-0.05), REI: 8.42 (-0.19), SNMX: 2.49 (+0.05)

BUYINS.NET: SNMX, USG, E, GB, SXL, AT Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Tue Dec 08, 7:10AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Senomyx Inc (NASDAQ:SNMX), USG Corp (NYSE:USG), Eni SpA (NYSE:E), Greatbatch Inc (NYSE:GB), Slam Exploration Ltd (NYSE:SXL), ATLANTIC POWER CORP (NYSE:AT) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
AT: 2.57 (+0.17), E: 32.19 (+0.98), GB: 30.93 (+0.63), USG: 28.26 (+0.46), SNMX: 2.49 (+0.05), SXL: 28.40 (+0.53)

Traders Get Bullish on Shares of Senomyx, Shares Up 6.3% (SNMX)
Comtex SmarTrend(R) - Mon Nov 30, 11:41AM CST
Senomyx (NASDAQ:SNMX) is one of today's best performing low-priced stocks, up 6.3% to $4.74 on 1.3x average daily volume. Senomyx has traded 336,000 shares thus far today, vs. average volume of 253,000 shares per day. The stock has outperformed the Dow (6.3% to the Dow's -0.2%) and outperformed the S&P 500 (6.3% to the S&P's -0.2%) during today's trading.
SNMX: 2.49 (+0.05)

Where Opportunity is Found - Research on Ballard Power Systems, Mattson Technology, Senomyx and EMCORE
ACCESSWIRE - Fri Nov 20, 6:55AM CST
NEW YORK, NY / ACCESSWIRE / November 20, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Ballard Power Systems Inc. (NASDAQ: BLDP), Mattson Technology Inc. (NASDAQ: MTSN), Senomyx Inc. (NASDAQ: SNMX) and EMCORE Corp. (NASDAQ: EMKR). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
BLDP: 1.29 (+0.03), EMKR: 6.31 (+0.13), MTSN: 3.60 (unch), SNMX: 2.49 (+0.05)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 98

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 63

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 146

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
PZZA Faces Class Action: Strategic Shake-up or Misstep?

Updated Category News Views 10

Papa John's: Doughy Deceit or Strategic Misfire? Once in a while, a corporation trips over its own ambitious production line, and Papa John’s (NASDAQ:PZZA) is the latest contestant to make headlines for all the wrong reasons. Investors in this pizza powerhouse are being called to the courtroom as a class action lawsuit unfolds, marking a turbulent stage in the...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 79

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 125

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Beta Bionics Faces Class Action Lawsuit Amid FDA Concerns

Updated Category News Views 240

Beta Bionics in the Legal Crosshairs When a company like Beta Bionics gets hauled into court, you know it's not just smoky mirrors and boardroom politics. The stakes are high right now, with investors lining up for a class-action lawsuit that zeroes in on a nasty bundle of allegations. This isn't just a blip on the radar. It's a seismic wave in the industry. Allegations...

Continue Reading
Wisconsin Brats Clash with Florida Citrus in Marketing Showdown

Updated Category News Views 26

A Juicy Rivalry with Sweet and Savory Stakes You ever catch yourself watching state pride turn into a marketing showdown? That's what's cookin' with Wisconsin's Johnsonville and Florida's Natural, and believe me, this isn't just about what’s on your plate. Forget the foam fingers, here it's all about the brats and the OJ. It's like the Packers versus the Dolphins, but...

Continue Reading
Pathalys' Phase 3 Data Shows Promise for CKD Drug

Updated Category News Views 63

A Glimpse at Pathalys Pharma's Recent Win This is some groundbreaking stuff emerging from Pathalys Pharma. Their investigational drug, upacicalcet, has just clinched a significant victory in two crucial Phase 3 trials - PATH-1 and PATH-2 - aimed at treating Secondary Hyperparathyroidism (SHPT) in patients with end-stage kidney disease undergoing hemodialysis. With SHPT...

Continue Reading
DigitalXForce Booms with 514% Growth and Major Backing

Updated Category News Views 184

Massive Growth and Strategic Investment in DigitalXForce Now here’s a company that’s shaking things up—DigitalXForce. Right on the back of a staggering 514% growth, they’ve corralled a strategic investment from Arsenal Growth Equity. If you blink, you might miss just how fast they’re sprinting through the tech landscape. Institutional Support Backing the...

Continue Reading

Top 5 Most Recently Viewed Articles

California Science Center Celebrates Topping Out New Space Center

Updated Category News Views 338

California Science Center Celebrates Construction Milestone The California Science Center has recently achieved a remarkable milestone in the construction of the future Samuel Oschin Air and Space Center. The topping out ceremony celebrated the placement of some of the final steel beams in the innovative diagrid roof structure, which is set to become an iconic part of the...

Continue Reading
Analysis of Trump's Tax Proposal: Who Benefits Most?

Updated Category News Views 355

Trump's tax proposal hit the scene back in 2024, causing a storm of chatter among traders and economists. The thing was a mixed bag—while it looked like a goldmine for the wealthy, everyone else seemed to be left holding the short end of the stick. The Wealth Disparity Play: Tax Cuts or Tax Burdens? A detailed analysis from ITEP threw some serious numbers into the ring....

Continue Reading
MotherDuck Launches pg_duckdb to Revolutionize PostgreSQL Queries

Updated Category News Views 194

MotherDuck Introduces pg_duckdb for Enhanced Analytics MotherDuck is making waves in the data analytics world with the launch of its new PostgreSQL extension called pg_duckdb. This innovative tool brings the robust analytics capabilities of DuckDB right into the PostgreSQL environment, allowing businesses to execute sophisticated analytical queries without disrupting...

Continue Reading
Intel Corporation's Strategic Moves and Stock Performance Unveiled

Updated Category News Views 227

Intel Corporation's Latest Stock Surge Intel Corporation (NASDAQ: INTC) achieved an impressive stock gain of 4.84%, closing at $23.07 on a recent trading day. This surge reflects the company's vigorous restructuring efforts aimed at redefining its business operations. As industry dynamics shift, Intel is undergoing significant transformations to bolster its market...

Continue Reading
EagleView Introduces Comprehensive Property Data Ecosystem

Updated Category News Views 183

EagleView Brings Forth an Innovative Property Data Solution EagleView, a prominent player in aerial imagery, has unveiled its latest property data ecosystem, a significant leap forward in how property insights can be gathered and utilized. This new initiative encompasses over 60 petabytes of data, derived from high-definition aerial imagery, designed to provide invaluable...

Continue Reading